212 related articles for article (PubMed ID: 1563835)
1. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1992 Apr; 51(1):144-8. PubMed ID: 1563835
[TBL] [Abstract][Full Text] [Related]
2. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
Stanwell C; Gescher A; Bradshaw TD; Pettit GR
Int J Cancer; 1994 Feb; 56(4):585-92. PubMed ID: 8112895
[TBL] [Abstract][Full Text] [Related]
3. Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells.
Dale IL; Gescher A
Int J Cancer; 1989 Jan; 43(1):158-63. PubMed ID: 2910827
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
Dale IL; Bradshaw TD; Gescher A; Pettit GR
Cancer Res; 1989 Jun; 49(12):3242-5. PubMed ID: 2720677
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
Boorne AJ; Donnelly N; Schrey MP
Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
[TBL] [Abstract][Full Text] [Related]
8. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C; Budworth J; Gescher A
Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
[TBL] [Abstract][Full Text] [Related]
10. Involvement of phospholipase D and protein kinase C in phorbol ester and fatty acid stimulated turnover of phosphatidylcholine and phosphatidylethanolamine in neural cells.
Cook HW; Ridgway ND; Byers DM
Biochim Biophys Acta; 1998 Feb; 1390(1):103-17. PubMed ID: 9487144
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition by staurosporine of phorbol ester, bryostatin and okadaic acid effects on mouse skin.
Gschwendt M; Kittstein W; Lindner D; Marks F
Cancer Lett; 1992 Sep; 66(2):139-46. PubMed ID: 1394118
[TBL] [Abstract][Full Text] [Related]
12. The effect of fetal calf serum on growth arrest caused by activators of protein kinase C.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1991 Apr; 47(6):929-32. PubMed ID: 1707036
[TBL] [Abstract][Full Text] [Related]
13. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM
Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells.
Jalava A; Lintunen M; Heikkilä J
Biochem Biophys Res Commun; 1993 Mar; 191(2):472-8. PubMed ID: 8461005
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C agonist and antagonist effects in normal human epidermal keratinocytes.
Matsui MS; Illarda I; Wang N; DeLeo VA
Exp Dermatol; 1993 Dec; 2(6):247-56. PubMed ID: 8162345
[TBL] [Abstract][Full Text] [Related]
16. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
[TBL] [Abstract][Full Text] [Related]
17. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
Levine BL; May WS; Tyler PG; Hess AD
J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742
[TBL] [Abstract][Full Text] [Related]
18. Selective activation by bryostatin-1 demonstrates unique roles for PKC epsilon in neurite extension and tau phosphorylation.
Ekinci FJ; Shea TB
Int J Dev Neurosci; 1997 Nov; 15(7):867-74. PubMed ID: 9568534
[TBL] [Abstract][Full Text] [Related]
19. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
Steube KG; Grunicke D; Drexler HG
Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
Gschwend JE; Fair WR; Powell CT
Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]